Largest pharmaceuticals by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceuticals ranked by total liabilities, at SGD 176.9B, ahead of Pfizer (SGD 156.5B) and Johnson & Johnson (SGD 151.7B). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieSGD 176.9B
- Median
- SGD 2.7B
- Combined market value
- SGD 6.61T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SGD 176.9B | SGD 663.2B | SGD 375.20 | 0.63% down | 26% up | ||
| 2 | PfizerPFE · Health Care | SGD 156.5B | SGD 208B | SGD 36.50 | 0.58% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | SGD 151.7B | SGD 860.3B | SGD 357.35 | 0.56% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | SGD 110.8B | SGD 1.61T | SGD 1,807.44 | 0.98% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | SGD 108.6B | SGD 449.9B | SGD 182.49 | 1.29% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | SGD 92.2B | SGD 159.9B | SGD 78.23 | 1.12% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | SGD 84.3B | SGD 360.8B | SGD 232.63 | 1.02% down | 2% up | ||
| 8 | NovartisNVS · Health Care | SGD 83B | SGD 383.1B | SGD 202.83 | 1.15% down | 25% up | ||
| 9 | SanofiSNY · Health Care | SGD 78.8B | SGD 147.3B | SGD 61.33 | 0.06% up | 4% down | ||
| 10 | GSKGSK · Health Care | SGD 77.3B | SGD 127B | SGD 63.38 | 0.18% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | SGD 66.8B | SGD 228.4B | SGD 51.82 | 1.25% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | SGD 65.3B | SGD 88.6B | SGD 27.74 | 0.60% down | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | SGD 43.8B | SGD 234.2B | SGD 135.23 | 0.15% up | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 42.3B | SGD 64.5B | SGD 55.28 | 0.59% up | 74% up | ||
| 15 | ViatrisVTRS · Health Care | SGD 29B | SGD 30.6B | SGD 26.69 | 1.20% up | 96% up | ||
| 16 | GrifolsGRFS · Health Care | SGD 17.3B | SGD 7.5B | SGD 11.09 | 0.35% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | SGD 15.6B | SGD 43.9B | SGD 107.98 | 0.31% up | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | SGD 12.8B | SGD 51.1B | SGD 88.82 | 0.29% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | SGD 12B | SGD 128.3B | SGD 1,240.19 | 0.42% up | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 9.5B | SGD 20.1B | SGD 313.13 | 0.88% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | SGD 9.1B | SGD 41.1B | SGD 66.67 | 0.50% down | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | SGD 9B | SGD 177B | SGD 697.99 | 1.33% up | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | SGD 8.8B | SGD 17B | SGD 33.94 | 1.82% up | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SGD 5.4B | SGD 26.9B | SGD 201.18 | 0.31% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | SGD 4.9B | SGD 59.9B | SGD 524.01 | 1.67% down | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | SGD 4.7B | SGD 9.7B | SGD 27.75 | 1.89% up | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | SGD 4B | SGD 6.5B | SGD 78.17 | 0.43% up | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | SGD 3.9B | SGD 5.9B | SGD 35.32 | 1.59% up | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | SGD 3.9B | SGD 19.5B | SGD 100.27 | 1.25% up | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 2.7B | SGD 16.1B | SGD 19.31 | 1.18% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | SGD 2.7B | SGD 9.4B | SGD 67.79 | 1.78% up | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | SGD 2.1B | SGD 22.9B | SGD 349.77 | 0.02% up | 28% up | ||
| 33 | InsmedINSM · Health Care | SGD 2B | SGD 34.5B | SGD 157.23 | 0.06% up | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | SGD 1.9B | SGD 14.8B | SGD 76.48 | 1.37% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.1B | SGD 8B | SGD 56.35 | 1.65% up | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | SGD 1B | SGD 31.9B | SGD 748.40 | 0.63% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | SGD 943.4M | SGD 4.1B | SGD 21.19 | 1.99% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | SGD 861M | SGD 10B | SGD 59.77 | 1.99% up | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 847.1M | SGD 12.6B | SGD 542.09 | 0.38% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | SGD 775.6M | SGD 9.2B | SGD 174.08 | 0.70% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | SGD 700.7M | SGD 7.6B | SGD 382.17 | 0.87% up | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SGD 681M | SGD 7.7B | SGD 118.65 | 0.07% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | SGD 632.3M | SGD 6.3B | SGD 65.47 | 0.64% down | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | SGD 536.8M | SGD 36.6B | SGD 50.47 | 1.11% up | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | SGD 535.4M | SGD 12.5B | SGD 82.45 | 1.96% up | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | SGD 388.4M | SGD 6.4B | SGD 36.56 | 1.80% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 271M | SGD 10.4B | SGD 150.01 | 0.24% down | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 252.8M | SGD 9.8B | SGD 124.58 | 1.58% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | SGD 243.5M | SGD 9.9B | SGD 90.37 | 0.02% up | 8% down | ||
| 50 | ABIVAXABVX · Health Care | SGD 184.8M | SGD 9.5B | SGD 108.27 | 2.27% up | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | SGD 139M | SGD 5.2B | SGD 38.10 | 0.56% up | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | SGD 119M | SGD 11.7B | SGD 14.57 | 5.93% up | 36% down | ||
| 53 | ErascaERAS · Health Care | SGD 91.5M | SGD 6.1B | SGD 17.47 | 2.48% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SGD 80.6M | SGD 11.8B | SGD 123.76 | 2.31% up | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | SGD 77.1M | SGD 11.2B | SGD 400.91 | 1.92% up | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | SGD 69M | SGD 10.6B | SGD 162.44 | 1.05% up | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | SGD 48.4M | SGD 6.4B | SGD 113.43 | 1.14% up | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | SGD 39.1M | SGD 5.9B | SGD 53.61 | 1.11% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | SGD 21.5M | SGD 8.6B | SGD 126.38 | 1.75% up | 241% up | ||
| 60 | Belite BioBLTE · Health Care | SGD 13M | SGD 8.3B | SGD 203.66 | 0.14% up | 31% up | ||
| 61 | VeradermicsMANE · Health Care | SGD 11.8M | SGD 6.9B | SGD 163.53 | 0.94% up | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2895 SGD).
Questions and answers
Which pharmaceuticals rank first by total liabilities?
AbbVie (SGD 176.9B), Pfizer (SGD 156.5B) and Johnson & Johnson (SGD 151.7B) are the top three of the 61 pharmaceuticals ranked by total liabilities as of 18 Nov 2026, 15:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by total liabilities have a combined market value of SGD 6.61T as of 18 Nov 2026, 15:06 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.